During pregnancy, which anticonvulsants are associated with the greatest fetal risk?

During pregnancy, which anticonvulsants are associated with the greatest fetal risk?

• A. Carbamazepine and Valproate
• B. Lamotrigine
• C. Levetiracetam and Gabapentin
• D. Topiramate and Clonazepam

Answer: (A)

Exposure to valproate during pregnancy carries the highest risk for the fetus. It is strongly linked to major congenital malformations, especially neural tube defects, and it’s associated with poorer neurodevelopmental outcomes. Carbamazepine also has teratogenic potential, including neural tube and other defects, but the overall risk is generally lower than with valproate. Other anticonvulsants like lamotrigine and levetiracetam tend to have relatively lower documented risks, while topiramate has some association with orofacial clefts and benzodiazepines such as clonazepam can cause neonatal sedation or respiratory issues. So, the greatest fetal risk among these options comes from valproate, with carbamazepine still notable but not as high.

Exposure to valproate during pregnancy carries the highest risk for the fetus. It is strongly linked to major congenital malformations, especially neural tube defects, and it’s associated with poorer neurodevelopmental outcomes. Carbamazepine also has teratogenic potential, including neural tube and other defects, but the overall risk is generally lower than with valproate. Other anticonvulsants like lamotrigine and levetiracetam tend to have relatively lower documented risks, while topiramate has some association with orofacial clefts and benzodiazepines such as clonazepam can cause neonatal sedation or respiratory issues. So, the greatest fetal risk among these options comes from valproate, with carbamazepine still notable but not as high.